Trinity Capital upgraded by Compass Point with a new price target
$TRIN
Finance: Consumer Services
Finance
Compass Point upgraded Trinity Capital from Neutral to Buy and set a new price target of $15.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/13/2025 | $16.00 | Buy | B. Riley Securities |
| 12/2/2024 | $13.00 | Equal Weight → Underweight | Wells Fargo |
| 8/22/2023 | $15.50 | Neutral → Buy | Compass Point |
| 8/7/2023 | $15.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 7/5/2023 | $15.00 | Buy | Jefferies |
| 3/13/2023 | $13.50 → $11.00 | Mkt Perform → Underperform | Keefe Bruyette |
| 11/7/2022 | $30.00 | Positive → Neutral | Susquehanna |
| 11/4/2022 | $16.00 → $12.50 | Outperform → Mkt Perform | Keefe Bruyette |
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
B. Riley Securities resumed coverage of Trinity Capital with a rating of Buy and set a new price target of $16.00
Wells Fargo downgraded Trinity Capital from Equal Weight to Underweight and set a new price target of $13.00
Compass Point upgraded Trinity Capital from Neutral to Buy and set a new price target of $15.50
8-K - Trinity Capital Inc. (0001786108) (Filer)
144 - Trinity Capital Inc. (0001786108) (Subject)
10-Q - Trinity Capital Inc. (0001786108) (Filer)
22nd Consecutive Quarter of a Consistent or Increased Dividend PHOENIX, June 18, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced that its Board of Directors declared a cash dividend of $0.51 per share with respect to the quarter ending June 30, 2025. This is an equivalent dividend compared to the first quarter of 2025 and marks the 22nd consecutive quarter of a consistent or increased dividend for Trinity Capital shareholders. Summary of Second Quarter 2025 Dividend: Declaration Date June 18, 2025 Re
Funding supports Paytient's rapid growth as cost-smoothing becomes a standard component of modern benefit design COLUMBIA, Mo., June 3, 2025 /PRNewswire/ -- Paytient, the healthcare payments company helping people better access and afford care, has secured $40 million from Trinity Capital, a trusted partner for innovative companies seeking tailored growth capital solutions. The facility will support Paytient's expansion into large group employer-sponsored plans, alternative health plans, the ACA marketplace, and Medicare, as plan-embedded out-of-pocket affordability or cost-sm
PHOENIX, June 3, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity Capital"), a leading alternative asset manager, today announced the commitment of $40 million in growth capital to Paytient, a healthcare payments company helping people better access and afford care. Paytient enables employers and insurers to transform how cost share responsibility feels for patients. As part of the health plan, Paytient allows people to access care from providers and manage out-of-pocket healthcare costs over time, without interest or fees. Paytient's members can choose lower-
22nd Consecutive Quarter of a Consistent or Increased Dividend PHOENIX, June 18, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced that its Board of Directors declared a cash dividend of $0.51 per share with respect to the quarter ending June 30, 2025. This is an equivalent dividend compared to the first quarter of 2025 and marks the 22nd consecutive quarter of a consistent or increased dividend for Trinity Capital shareholders. Summary of Second Quarter 2025 Dividend: Declaration Date June 18, 2025 Re
Total Investment Income grows 29.5% year-over-year Net Asset Value reaches new high of $833 million Return on Average Equity registers at 15.5% PHOENIX, May 7, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity Capital" or "the Company"), a leading alternative asset manager, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Total investment income of $65.4 million, an increase of 29.5% year-over-yearNet investment income ("NII") of $32.4 million, or $0.52 per basic shareNet increase in net assets res
Company originates $186 million of new commitments in the first quarter of 2025 PHOENIX, April 9, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced a portfolio update for the first quarter of 2025. Trinity Capital funded $220 million of total investments and originated $186 million of new commitments in the first quarter of 2025. First quarter 2025 investment highlights: Investments funded totaled approximately $220 million, which was comprised of $148 million in secured loans, $71 million in equipment
PHOENIX, March 12, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading international alternative asset manager, today announced the appointment of Zach Taffet as Director of Capital Formation & Investor Relations. Mr. Taffet will help drive the strategic direction for the Company's private fund strategies and management of institutional capital through its RIA platform. Mr. Taffet brings nearly a decade of experience in capital raising and investor relations, most recently as a member of BlackRock's Infrastructure Capital Formation Team for their
PHOENIX, March 3, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced the appointment of John Orlando as Managing Director of Life Sciences, based in Boston. Mr. Orlando, an established leader with over a decade of experience in venture lending, has built a strong reputation as a trusted partner within the Life Sciences industry. "We are thrilled to welcome John to our team," said Rob Lake, Senior Managing Director, Life Sciences at Trinity Capital. "We believe his industry experience and deep relationsh
PHOENIX, July 22, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the appointment of Josh Ruben as Managing Director of Life Sciences. Mr. Ruben, an established leader with over a decade of experience in investment banking, has a long track record of supporting life science companies with over $50 billion of transactions completed across M&A and capital raises. He is based in Phoenix, AZ. "We are delighted to welcome Josh to our team," said